|
|
||||||||
Institute of Human Genetics, School of Clinical Medical Sciences, University of Newcastle, Newcastle upon Tyne, UK
(Requests for offprints should be addressed to Simon Pearce, Institute of Human Genetics, Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK; Email: s.h.s.pearce{at}ncl.ac.uk)
Previous studies have suggested an association between alleles of the CYP27B1 (1-
hydroxylase) gene and autoimmune conditions. We have examined three single nucleotide polymorphisms (SNPs) that are located in the 5' region and promoter of the CYP27B1 gene for association in a cohort of Graves disease and autoimmune Addisons disease subjects from the UK. Genomic DNA samples from white patients with autoimmune Addisons disease (n=104) and healthy controls (n=464) were genotyped by PCR-RFLP analysis for the SNPs at positions 1260 and 1077 5' of the coding CYP27B1 sequences. The 1260 SNP was also examined in a cohort of patients with Graves disease (n=446).
2 testing of contingency tables was used to determine the significance of genotypes and alleles. Haplotype frequencies and linkage disequilibrium measures were estimated using the UNPHASED and HAPLOVIEW packages. Alleles at the three CYP27B1 markers were in tight linkage disequilibrium with each other and all showed association with autoimmune Addisons disease. The maximum evidence for association was with the 1260 C allele (76.0% in Addisons subjects versus 64.9% in controls; P=0.003; odds ratio 1.71 (595% confidence intervals, 1.202.44). A global test of significance for the common 1918 T, 1260 C and 1077 G haplotype was significant in Addisons subjects compared with controls (P=0.01). In contrast, there was no association of alleles at the 1260 SNP with Graves disease. We are able to confirm that a CYP27B1 promoter allele is associated with autoimmune Addisons disease, and extend this finding to include an associated promoter haplotype.
This article has been cited by other articles:
![]() |
A. L. Mitchell, H. J. Cordell, R. Soemedi, K. Owen, B. Skinningsrud, A. B. Wolff, M. Ericksen, D. Undlien, E. Husebye, and S. H. S. Pearce Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison's Disease and Graves' Disease Susceptibility J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 5139 - 5145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Novakovic, M. Sibson, H. K. Ng, U. Manuelpillai, V. Rakyan, T. Down, S. Beck, T. Fournier, D. Evain-Brion, E. Dimitriadis, et al. Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene: IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE J. Biol. Chem., May 29, 2009; 284(22): 14838 - 14848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diorio, M. Sinotte, J. Brisson, S. Berube, and M. Pollak Vitamin D Pathway Polymorphisms in Relation to Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2505 - 2508. [Full Text] [PDF] |
||||
![]() |
B. Skinningsrud, E. S. Husebye, S. H. Pearce, D. O. McDonald, K. Brandal, A. B. Wolff, K. Lovas, T. Egeland, and D. E. Undlien Polymorphisms in CLEC16A and CIITA at 16p13 Are Associated with Primary Adrenal Insufficiency J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3310 - 3317. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |